Results
8518
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,518 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A441270 | ₩5,040.00 | -9.2% | -42.7% | ₩186.3b | n/a | PS0.5x | E135.0% | n/a | Tech | ||
A253590 | ₩10,060.00 | -5.7% | -4.3% | ₩427.5b | n/a | PE34.4x | E61.7% | 0.3% | Semiconductors | ||
GUINNESS | ₦77.00 | 10.0% | 20.9% | ₦168.7b | ₦74.24 | PS0.4x | E119.5% | 0% | Food, Beverage & Tobacco | ||
RMDA | ج.م3.71 | 7.8% | 90.2% | ج.م5.6b | ج.م5.02 | PE21x | E30.7% | 1.8% | Pharmaceuticals & Biotech | ||
300848 | CN¥16.77 | -1.0% | 62.7% | CN¥6.9b | CN¥15.00 | PE100.6x | E80.2% | 0.5% | Materials | ||
001389 | CN¥58.12 | -5.6% | n/a | CN¥24.7b | CN¥63.00 | n/a | E29.5% | 0.4% | Tech | ||
300432 | CN¥16.37 | -3.5% | 136.6% | CN¥20.0b | CN¥23.93 | PE117.6x | E71.0% | 0% | Automobiles | ||
FWRY | ج.م8.50 | -0.2% | 63.8% | ج.م29.0b | ج.م12.45 | PE23.4x | E27.4% | n/a | Diversified Financials | ||
SFPTECH | RM 0.69 | -2.8% | -22.6% | RM 1.6b | RM 0.96 | PE42.8x | E28.3% | 0.6% | Capital Goods | ||
600845 | CN¥28.88 | 0.2% | -15.5% | CN¥70.8b | CN¥35.12 | PE31.9x | E25.2% | 2.9% | Software | ||
603822 | CN¥49.65 | 2.8% | 133.6% | CN¥3.8b | n/a | PS2.5x | E110.7% | 0% | Materials | ||
003006 | CN¥23.42 | -0.6% | 69.3% | CN¥10.1b | CN¥28.50 | PE34.2x | E25.5% | 2.3% | Household | ||
002970 | CN¥44.89 | -5.3% | 85.7% | CN¥7.8b | CN¥75.41 | PE32.6x | E32.9% | 1.1% | Automobiles | ||
002827 | CN¥24.16 | -0.8% | 78.7% | CN¥6.7b | n/a | PE53.1x | E46.7% | 0.6% | Materials | ||
605499 | CN¥243.15 | 0.1% | 94.3% | CN¥126.4b | CN¥262.72 | PE40.9x | E25.1% | 0.8% | Food, Beverage & Tobacco | ||
600760 | CN¥46.56 | -0.7% | 31.4% | CN¥128.3b | CN¥53.90 | PE52.1x | E29.4% | 0.3% | Capital Goods | ||
ALKT | US$36.26 | 2.7% | 47.3% | US$3.6b | US$45.10 | PS11.5x | E102.7% | n/a | Software | ||
ALNY | US$273.99 | 2.8% | 58.5% | US$36.0b | US$299.74 | PS16.9x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
KINS | US$16.23 | 5.3% | 405.6% | US$192.6m | US$18.00 | PE12.6x | E24.9% | 0% | Insurance | ||
TVTX | US$20.45 | 5.1% | 129.0% | US$1.8b | US$28.47 | PS8.7x | E62.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.40 | 10.8% | -43.9% | US$251.9m | US$17.08 | PS4.1x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$105.14 | 2.8% | 16.8% | US$5.0b | US$132.13 | PS15.1x | E58.1% | n/a | Pharmaceuticals & Biotech | ||
LAVV3 | R$8.16 | 4.1% | 5.3% | R$1.6b | R$12.65 | PE5.1x | E20.5% | 3.5% | Real Estate Management and Development | ||
300286 | CN¥19.48 | -3.5% | 1.5% | CN¥4.1b | CN¥33.30 | PE22.2x | E32.0% | 1.0% | Capital Goods |